Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline ...
Q1 2026
Mar 31, 2026
FY 2025
Dec 31, 2025
Q4 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025